Profile data is unavailable for this security.
About the company
Baxter International Inc. is a global medtech company. Its segments include Medical Products and Therapies, Healthcare Systems and Technologies, and Pharmaceuticals. The Medical Products and Therapies segment includes sales of its sterile IV solutions, infusion systems, administration sets, parenteral nutrition therapies and surgical hemostat, sealant, and adhesion prevention products. The Healthcare Systems and Technologies segment includes sales of its connected care solutions and collaboration tools, including smart bed systems, patient monitoring systems and diagnostic technologies, respiratory health devices, and advanced equipment for the surgical space, including operating room integration technologies, precision positioning devices, and other accessories. The Pharmaceuticals segment includes sales of specialty injectable pharmaceuticals, inhaled anesthesia, and drug compounding. It provides a portfolio of diagnostic, critical care, nutrition, hospital and surgical products.
- Revenue in USD (TTM)10.77bn
- Net income in USD-277.00m
- Incorporated1931
- Employees38.00k
- LocationBaxter International IncOne Baxter ParkwayDEERFIELD 60015United StatesUSA
- Phone+1 (224) 948-2000
- Fax+1 (302) 655-5049
- Websitehttps://www.baxter.com/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Masimo Corp | 1.97bn | -276.60m | 9.12bn | 3.60k | -- | 9.63 | -- | 4.62 | -5.17 | -9.21 | 36.51 | 17.46 | 0.7517 | 2.42 | 6.30 | 548,222.30 | -10.54 | 3.29 | -13.17 | 3.99 | 50.50 | 53.94 | -14.02 | 4.56 | 1.62 | 2.12 | 0.4075 | 0.00 | 2.26 | 17.43 | -474.11 | -- | -6.75 | -- |
Henry Schein Inc | 12.67bn | 407.00m | 9.13bn | 25.00k | 22.71 | 2.70 | 13.10 | 0.7208 | 3.22 | 3.22 | 100.12 | 27.08 | 1.23 | 4.91 | 7.86 | 506,760.00 | 3.88 | 5.43 | 6.38 | 9.19 | 31.60 | 30.23 | 3.16 | 3.98 | 0.7525 | 6.94 | 0.3799 | 0.00 | 2.71 | 4.88 | -6.25 | -11.06 | 19.66 | -- |
Avantor Inc | 6.69bn | 715.60m | 9.17bn | 13.50k | 12.82 | 1.50 | 8.18 | 1.37 | 1.05 | 1.05 | 9.80 | 8.95 | 0.5329 | 5.69 | 6.01 | 495,200.00 | 5.70 | 3.94 | 6.62 | 4.48 | 33.56 | 33.76 | 10.70 | 6.87 | 0.7532 | 3.95 | 0.4024 | 0.00 | -2.64 | 2.35 | 121.58 | -- | 23.59 | -- |
Penumbra Inc | 1.24bn | 42.23m | 9.94bn | 4.50k | 250.16 | 8.18 | 156.68 | 8.01 | 1.03 | 1.03 | 31.38 | 31.35 | 0.7816 | 1.02 | 6.89 | 275,577.80 | 2.66 | 1.42 | 2.95 | 1.58 | 66.37 | 63.21 | 3.41 | 1.96 | 3.68 | -- | 0.019 | 0.00 | 12.86 | 16.89 | -84.59 | -21.98 | -0.853 | -- |
Revvity Inc | 2.77bn | 296.04m | 11.40bn | 11.00k | 39.94 | 1.51 | 15.98 | 4.12 | 2.42 | 2.35 | 22.70 | 63.96 | 0.2148 | 3.05 | 4.59 | 251,806.20 | 2.30 | 4.31 | 2.49 | 4.84 | 56.25 | 58.50 | 10.69 | 15.78 | 2.99 | 14.59 | 0.2932 | 6.52 | 0.162 | -0.9086 | 57.70 | 4.20 | 1.27 | 4.56 |
Solventum Corp | 8.31bn | 379.00m | 13.12bn | 22.00k | 34.86 | 4.02 | 14.22 | 1.58 | 2.18 | 2.18 | 47.69 | 18.85 | 0.5683 | 4.26 | 7.74 | 377,636.40 | 2.59 | -- | 3.05 | -- | 54.71 | -- | 4.55 | -- | 0.8523 | 1.93 | 0.7081 | -- | 0.6954 | -- | -64.41 | -- | -- | -- |
Align Technology Inc | 3.98bn | 409.56m | 13.72bn | 20.95k | 34.46 | 3.65 | 24.47 | 3.45 | 5.49 | 5.49 | 53.41 | 51.94 | 0.6495 | 4.55 | 3.96 | 190,061.70 | 6.68 | 13.90 | 9.94 | 20.50 | 69.92 | 71.24 | 10.29 | 20.95 | 1.08 | -- | 0.00 | 0.00 | 3.54 | 10.69 | -5.32 | -0.9865 | -5.04 | -- |
Cooper Companies Inc | 3.99bn | 414.20m | 14.20bn | 16.00k | 34.50 | 1.71 | 18.25 | 3.56 | 2.06 | 2.06 | 19.86 | 41.54 | 0.3261 | 1.58 | 5.43 | 249,262.50 | 3.39 | 8.72 | 3.68 | 9.73 | 67.20 | 65.70 | 10.39 | 26.35 | 1.23 | 6.80 | 0.2378 | 0.282 | 8.41 | 7.98 | 33.34 | -3.17 | 7.59 | -- |
Hologic Inc | 4.03bn | 556.70m | 14.52bn | 7.06k | 27.51 | 3.14 | 17.01 | 3.61 | 2.37 | 2.37 | 17.31 | 20.73 | 0.4666 | 2.57 | 6.24 | 570,083.60 | 6.45 | 13.12 | 7.27 | 15.20 | 56.44 | 60.82 | 13.83 | 24.75 | 2.52 | 110.53 | 0.354 | 0.00 | -0.0025 | 3.66 | 73.14 | -- | 4.30 | -- |
Illumina Inc | 4.34bn | -965.00m | 15.10bn | 8.97k | -- | 6.41 | -- | 3.48 | -6.10 | -6.10 | 27.23 | 14.89 | 0.5347 | 2.60 | 6.36 | 483,500.60 | -11.90 | -10.33 | -14.50 | -12.15 | 66.34 | 65.65 | -22.25 | -25.30 | 1.48 | 17.30 | 0.4566 | -- | -2.93 | 4.29 | -5.34 | -- | -9.34 | -- |
Baxter International Inc | 10.77bn | -277.00m | 15.54bn | 38.00k | -- | 2.19 | 22.04 | 1.44 | -0.5388 | -1.10 | 21.03 | 13.80 | 0.4388 | 2.64 | 5.04 | 283,447.40 | -1.09 | -0.8441 | -1.37 | -1.03 | 36.73 | 38.63 | -2.49 | -2.03 | 1.40 | 3.65 | 0.5882 | -- | 2.66 | -1.31 | -293.68 | -- | -8.52 | 4.12 |
West Pharmaceutical Services Inc | 2.90bn | 467.20m | 15.72bn | 10.60k | 34.37 | 5.86 | 25.64 | 5.43 | 6.37 | 6.37 | 39.47 | 37.37 | 0.8021 | 4.63 | 5.30 | 273,188.70 | 12.56 | 15.61 | 15.00 | 18.70 | 34.54 | 38.00 | 15.66 | 18.84 | 2.03 | -- | 0.0716 | 10.20 | -1.92 | 9.48 | -16.97 | 15.31 | 24.43 | 5.84 |
Zimmer Biomet Holdings Inc | 7.70bn | 913.40m | 18.05bn | 17.00k | 20.21 | 1.46 | 9.36 | 2.34 | 4.51 | 4.51 | 38.06 | 62.63 | 0.3529 | 0.9622 | 5.17 | 452,852.90 | 4.19 | 2.34 | 4.75 | 2.68 | 71.05 | 71.18 | 11.88 | 7.60 | 1.46 | 6.46 | 0.3665 | 37.52 | 3.85 | -0.7725 | -11.74 | 2.05 | -3.69 | 0.00 |
Waters Corp | 2.98bn | 657.02m | 20.77bn | 7.60k | 31.68 | 10.58 | 24.41 | 6.96 | 11.02 | 11.02 | 50.04 | 32.98 | 0.6556 | 2.31 | 4.45 | 392,533.30 | 14.44 | 18.41 | 18.02 | 23.46 | 59.27 | 58.71 | 22.02 | 22.81 | 1.28 | 13.77 | 0.426 | 0.00 | 0.0667 | 4.22 | -0.6851 | 1.61 | -2.75 | -- |
Holder | Shares | % Held |
---|---|---|
The Vanguard Group, Inc.as of 31 Mar 2025 | 58.59m | 11.45% |
Dodge & Coxas of 31 Mar 2025 | 51.46m | 10.06% |
Pzena Investment Management LLCas of 31 Mar 2025 | 36.77m | 7.19% |
BlackRock Fund Advisorsas of 31 Mar 2025 | 30.27m | 5.92% |
SSgA Funds Management, Inc.as of 31 Mar 2025 | 21.77m | 4.25% |
T. Rowe Price Associates, Inc. (IM)as of 31 Mar 2025 | 19.57m | 3.82% |
BlackRock Advisors LLCas of 31 Mar 2025 | 16.77m | 3.28% |
Geode Capital Management LLCas of 31 Mar 2025 | 12.56m | 2.45% |
Harris Associates LPas of 31 Mar 2025 | 9.00m | 1.76% |
Newton Investment Management North America LLCas of 31 Mar 2025 | 8.02m | 1.57% |